Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1988 Jun;62(6):2115–2123. doi: 10.1128/jvi.62.6.2115-2123.1988

Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.

S A Jenison 1, J M Firzlaff 1, A Langenberg 1, D A Galloway 1
PMCID: PMC253307  PMID: 2835513

Abstract

Human papillomavirus (HPVs) infect the genital epithelium and are found in proliferative lesions ranging from benign condylomata to invasive carcinomas. The immunological response to these infections is poorly understood because of the lack of purified viral antigens. In this study, bacterially derived fusion proteins expressing segments of all the major open reading frames (ORFs) of HPV type 6b (HPV-6b) have been used in Western blot (immunoblot) assays to detect antibodies directed against HPV-encoded proteins. The most striking reactivities present in sera from patients with genital warts were to the HPV-6b L1 ORF protein and, to a lesser extent, to the HPV-6b L2 ORF protein. Two cases of reactivity to HPV-6b E2 ORF were observed, but no reactivities were seen with other HPV-6b constructs. Two sera reacted with the HPV-16 L2 fusion protein, and two sera reacted with the HPV-16 E4 protein. The antibodies directed against the HPV-6b fusion proteins showed no cross-reactivity with comparable regions of the HPV-16 ORFs. This assay provides a useful approach for further studies of HPV serology.

Full text

PDF
2115

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Goffe A. P. Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests. Lancet. 1965 Dec 11;2(7424):1205–1207. doi: 10.1016/s0140-6736(65)90633-1. [DOI] [PubMed] [Google Scholar]
  2. BARRERA-ORO J. G., SMITH K. O., MELNICK J. L. Quantitation of papova virus particles in human warts. J Natl Cancer Inst. 1962 Sep;29:583–595. [PubMed] [Google Scholar]
  3. Boshart M., Gissmann L., Ikenberg H., Kleinheinz A., Scheurlen W., zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984 May;3(5):1151–1157. doi: 10.1002/j.1460-2075.1984.tb01944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chow L. T., Nasseri M., Wolinsky S. M., Broker T. R. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J Virol. 1987 Aug;61(8):2581–2588. doi: 10.1128/jvi.61.8.2581-2588.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cole S. T., Streeck R. E. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol. 1986 Jun;58(3):991–995. doi: 10.1128/jvi.58.3.991-995.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cubie H. A. Serological studies in a student population prone to infection with human papilloma virus. J Hyg (Lond) 1972 Dec;70(4):677–690. doi: 10.1017/s0022172400022531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Danos O., Giri I., Thierry F., Yaniv M. Papillomavirus genomes: sequences and consequences. J Invest Dermatol. 1984 Jul;83(1 Suppl):7s–11s. doi: 10.1111/1523-1747.ep12281115. [DOI] [PubMed] [Google Scholar]
  8. Doorbar J., Campbell D., Grand R. J., Gallimore P. H. Identification of the human papilloma virus-1a E4 gene products. EMBO J. 1986 Feb;5(2):355–362. doi: 10.1002/j.1460-2075.1986.tb04219.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dürst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3812–3815. doi: 10.1073/pnas.80.12.3812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gissmann L., Wolnik L., Ikenberg H., Koldovsky U., Schnürch H. G., zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A. 1983 Jan;80(2):560–563. doi: 10.1073/pnas.80.2.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goffe A. P., Almeida J. D., Brown F. Further information on the antibody response to wart virus. Lancet. 1966 Sep 17;2(7464):607–609. doi: 10.1016/s0140-6736(66)91925-8. [DOI] [PubMed] [Google Scholar]
  12. Hefton J. M., Eisinger M. A quantitative micro-complement fixation method in studies of human wart viruses. J Gen Virol. 1978 Jan;38(1):179–182. doi: 10.1099/0022-1317-38-1-179. [DOI] [PubMed] [Google Scholar]
  13. Jenson A. B., Rosenthal J. D., Olson C., Pass F., Lancaster W. D., Shah K. Immunologic relatedness of papillomaviruses from different species. J Natl Cancer Inst. 1980 Mar;64(3):495–500. [PubMed] [Google Scholar]
  14. Kienzler J. L., Lemoine M. T., Orth G., Jibard N., Blanc D., Laurent R., Agache P. Humoral and cell-mediated immunity to human papillomavirus type 1 (HPV-1) in human warts. Br J Dermatol. 1983 Jun;108(6):665–672. doi: 10.1111/j.1365-2133.1983.tb01078.x. [DOI] [PubMed] [Google Scholar]
  15. Komly C. A., Breitburd F., Croissant O., Streeck R. E. The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens. J Virol. 1986 Nov;60(2):813–816. doi: 10.1128/jvi.60.2.813-816.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lambert P. F., Spalholz B. A., Howley P. M. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell. 1987 Jul 3;50(1):69–78. doi: 10.1016/0092-8674(87)90663-5. [DOI] [PubMed] [Google Scholar]
  17. Li C. C., Shah K. V., Seth A., Gilden R. V. Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. J Virol. 1987 Sep;61(9):2684–2690. doi: 10.1128/jvi.61.9.2684-2690.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morison W. L. In vitro assay of immunity to human wart antigen. Br J Dermatol. 1975 Nov;93(5):545–552. doi: 10.1111/j.1365-2133.1975.tb02247.x. [DOI] [PubMed] [Google Scholar]
  19. Nakai Y., Lancaster W. D., Lim L. Y., Jenson A. B. Monoclonal antibodies to genus- and type-specific papillomavirus structural antigens. Intervirology. 1986;25(1):30–37. doi: 10.1159/000149652. [DOI] [PubMed] [Google Scholar]
  20. Ogilvie M. M. Serological studies with human papova (wart) virus. J Hyg (Lond) 1970 Sep;68(3):479–490. doi: 10.1017/s0022172400042388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Oriel J. D., Almeida J. D. Demonstration of virus particles in human genital warts. Br J Vener Dis. 1970 Feb;46(1):37–42. doi: 10.1136/sti.46.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Orth G., Breitburd F., Favre M. Evidence for antigenic determinants shared by the structural polypeptides of (Shope) rabbit papillomavirus and human papillomavirus type 1. Virology. 1978 Dec;91(2):243–255. doi: 10.1016/0042-6822(78)90373-2. [DOI] [PubMed] [Google Scholar]
  23. Orth G., Favre M., Croissant O. Characterization of a new type of human papillomavirus that causes skin warts. J Virol. 1977 Oct;24(1):108–120. doi: 10.1128/jvi.24.1.108-120.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pass F., Maizel J. V., Jr Wart-associated antigens. II. Human immunity to viral structural proteins. J Invest Dermatol. 1973 May;60(5):307–311. doi: 10.1111/1523-1747.ep12723136. [DOI] [PubMed] [Google Scholar]
  25. Pass F., Reissig M., Shah K. V., Eisinger M., Orth G. Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis. J Natl Cancer Inst. 1977 Oct;59(4):1107–1112. doi: 10.1093/jnci/59.4.1107. [DOI] [PubMed] [Google Scholar]
  26. Pfister H. Biology and biochemistry of papillomaviruses. Rev Physiol Biochem Pharmacol. 1984;99:111–181. doi: 10.1007/BFb0027716. [DOI] [PubMed] [Google Scholar]
  27. Pfister H., Huchthausen B., Gross G., zur Hausen H. Seroepidemiologic studies of bovine papillomavirus infections. J Natl Cancer Inst. 1979 Jun;62(6):1423–1425. [PubMed] [Google Scholar]
  28. Pyrhönen S. Hunan wart-virus antibodies in patients with genital and skin warts. Acta Derm Venereol. 1978;58(5):427–432. [PubMed] [Google Scholar]
  29. Pyrhönen S., Jablonska S., Obałek S., Kuismanen E. Immune reactions in epidermodysplasia verruciformis. Br J Dermatol. 1980 Mar;102(3):247–254. doi: 10.1111/j.1365-2133.1980.tb08136.x. [DOI] [PubMed] [Google Scholar]
  30. Pyrhönen S., Johansson E. Regression of warts. An immunological study. Lancet. 1975 Mar 15;1(7907):592–596. doi: 10.1016/s0140-6736(75)91880-2. [DOI] [PubMed] [Google Scholar]
  31. Pyrhönen S., Penttinen K. Wart-virus antibodies and the prognosis of wart disease. Lancet. 1972 Dec 23;2(7791):1330–1332. doi: 10.1016/s0140-6736(72)92776-6. [DOI] [PubMed] [Google Scholar]
  32. Schwarz E., Dürst M., Demankowski C., Lattermann O., Zech R., Wolfsperger E., Suhai S., zur Hausen H. DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J. 1983;2(12):2341–2348. doi: 10.1002/j.1460-2075.1983.tb01744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Seedorf K., Krämmer G., Dürst M., Suhai S., Röwekamp W. G. Human papillomavirus type 16 DNA sequence. Virology. 1985 Aug;145(1):181–185. doi: 10.1016/0042-6822(85)90214-4. [DOI] [PubMed] [Google Scholar]
  34. Spalholz B. A., Yang Y. C., Howley P. M. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell. 1985 Aug;42(1):183–191. doi: 10.1016/s0092-8674(85)80114-8. [DOI] [PubMed] [Google Scholar]
  35. Stanley K. K., Luzio J. P. Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. EMBO J. 1984 Jun;3(6):1429–1434. doi: 10.1002/j.1460-2075.1984.tb01988.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES